Literature DB >> 21140222

Meta-analysis of TYK2 gene polymorphisms association with susceptibility to autoimmune and inflammatory diseases.

Jin-Hui Tao1, Yan-Feng Zou, Xiao-Liang Feng, Jing Li, Fang Wang, Fan-Ming Pan, Dong-Qing Ye.   

Abstract

The aim of our meta-analysis was to quantitatively summarize the association of TYK2 gene polymorphisms with autoimmune and inflammatory diseases. 11 studies that included data from 21497 cases and 22647 controls were identified. OR was used as a measure of the effect of the association in a fixed/random effect model. Meta-analysis was performed for six TYK2 gene polymorphisms (rs34536443, rs2304256, rs280523, rs280519, rs12720270 and rs12720356). Significant association was found in rs34536443 (C versus G: OR = 0.76, 95% CI = 0.69-0.84, P < 0.00001; GC + CC versus GG: OR = 0.78, 95% CI = 0.68-0.90, P = 0.0005; CC versus GG + GC: OR = 0.76, 95% CI = 0.28-2.05, P = 0.58; CC versus GG: OR = 0.74, 95% CI = 0.27-2.02, P = 0.56; GC versus GG: OR = 0.78, 95% CI = 0.68-0.90, P = 0.0006) and rs2304256 (A versus C: OR = 0.78, 95% CI = 0.70-0.87, P < 0.0001; CA + AA versus CC: OR = 0.69, 95% CI = 0.59-0.81, P < 0.0001; AA versus CC + CA: OR = 0.75, 95% CI = 0.66-1.00, P = 0.05; AA versus CC: OR = 0.64, 95% CI = 0.47-0.86, P = 0.003; CA versus CC: OR = 0.70, 95% CI = 0.60-0.83, P < 0.0001) in TYK2 gene, but not for the other polymorphisms (rs280523, rs280519, rs12720270, and rs12720356). This meta-analysis demonstrates that autoimmune and inflammatory diseases is associated with TYK2 gene rs34536443 and rs2304256 polymorphisms, but not rs280523, rs280519, rs12720270 and rs12720356.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21140222     DOI: 10.1007/s11033-010-0601-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  35 in total

Review 1.  Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways?

Authors:  K G Becker
Journal:  Diabetes       Date:  1999-07       Impact factor: 9.461

Review 2.  Autoimmune disease: why and where it occurs.

Authors:  P Marrack; J Kappler; B L Kotzin
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

3.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

Review 4.  Signal transduction by type I interferons.

Authors:  Michael David
Journal:  Biotechniques       Date:  2002-10       Impact factor: 1.993

Review 5.  Mapping autoimmunity genes.

Authors:  M M Griffiths; J A Encinas; E F Remmers; V K Kuchroo; R L Wilder
Journal:  Curr Opin Immunol       Date:  1999-12       Impact factor: 7.486

6.  Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.

Authors:  Anna Hellquist; Tiina M Järvinen; Sari Koskenmies; Marco Zucchelli; Christina Orsmark-Pietras; Linda Berglind; Jaana Panelius; Taina Hasan; Heikki Julkunen; Mauro D'Amato; Ulpu Saarialho-Kere; Juha Kere
Journal:  J Rheumatol       Date:  2009-06-30       Impact factor: 4.666

7.  Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1.

Authors:  M F Richter; G Duménil; G Uzé; M Fellous; S Pellegrini
Journal:  J Biol Chem       Date:  1998-09-18       Impact factor: 5.157

8.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

9.  Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus.

Authors:  Snaevar Sigurdsson; Gunnel Nordmark; Harald H H Göring; Katarina Lindroos; Ann-Christin Wiman; Gunnar Sturfelt; Andreas Jönsen; Solbritt Rantapää-Dahlqvist; Bozena Möller; Juha Kere; Sari Koskenmies; Elisabeth Widén; Maija-Leena Eloranta; Heikki Julkunen; Helga Kristjansdottir; Kristjan Steinsson; Gunnar Alm; Lars Rönnblom; Ann-Christine Syvänen
Journal:  Am J Hum Genet       Date:  2005-01-18       Impact factor: 11.025

10.  Autoimmune thyroid disease in type I diabetic families.

Authors:  H Payami; S Joe; G Thomson
Journal:  Genet Epidemiol       Date:  1989       Impact factor: 2.135

View more
  23 in total

Review 1.  Janus kinases to jakinibs: from basic insights to clinical practice.

Authors:  Massimo Gadina; Mimi T Le; Daniella M Schwartz; Olli Silvennoinen; Shingo Nakayamada; Kunihiro Yamaoka; John J O'Shea
Journal:  Rheumatology (Oxford)       Date:  2019-02-01       Impact factor: 7.580

2.  Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population.

Authors:  Liang Tang; Pengcheng Wan; Yong Wang; Jiabao Pan; Yan Wang; Bifeng Chen
Journal:  Inflamm Res       Date:  2015-08-21       Impact factor: 4.575

Review 3.  Potential role of type I interferon in the pathogenic process leading to type 1 diabetes.

Authors:  Natasha Qaisar; Agata Jurczyk; Jennifer P Wang
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-04       Impact factor: 3.243

4.  The Immunogenetics of Systemic Sclerosis.

Authors:  Begüm Ünlü; Ümit Türsen; Zeynab Rajabi; Navid Jabalameli; Fateme Rajabi
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 5.  Viral infections in type 1 diabetes mellitus--why the β cells?

Authors:  Anne Op de Beeck; Decio L Eizirik
Journal:  Nat Rev Endocrinol       Date:  2016-03-29       Impact factor: 43.330

Review 6.  [Janus kinase inhibitors : State of the art in clinical use and future perspectives].

Authors:  R Alten; M Mischkewitz; A-L Stefanski; T Dörner
Journal:  Z Rheumatol       Date:  2020-04       Impact factor: 1.372

7.  Positive association between lymphotoxin-alpha variation rs909253 and cancer risk: a meta-analysis based on 36 case-control studies.

Authors:  Xi Yu; Yi Huang; Changhong Li; Hailian Yang; Caide Lu; Shiwei Duan
Journal:  Tumour Biol       Date:  2013-10-18

8.  Polymorphisms of DRD2 and DRD3 genes and Parkinson's disease: A meta-analysis.

Authors:  Dongjun Dai; Yunliang Wang; Lingyan Wang; Jinfeng Li; Qingqing Ma; Jianmin Tao; Xingyu Zhou; Hanlin Zhou; Yi Jiang; Guanghui Pan; Limin Xu; Ping Ru; Danfeng Lin; Jun Pan; Leiting Xu; Meng Ye; Shiwei Duan
Journal:  Biomed Rep       Date:  2014-01-13

9.  Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta-cell protection in type 1 diabetes.

Authors:  Alexandra Coomans de Brachène; Angela Castela; Anne Op de Beeck; Raghavendra G Mirmira; Lorella Marselli; Piero Marchetti; Craig Masse; Wenyan Miao; Silvana Leit; Carmella Evans-Molina; Decio L Eizirik
Journal:  Diabetes Obes Metab       Date:  2020-07-05       Impact factor: 6.577

10.  Whole-Exome Sequencing of Patients With Posterior Segment Uveitis.

Authors:  Angela S Li; Gabriel Velez; Benjamin Darbro; Marcus A Toral; Jing Yang; Stephen H Tsang; Polly J Ferguson; James C Folk; Alexander G Bassuk; Vinit B Mahajan
Journal:  Am J Ophthalmol       Date:  2020-07-21       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.